{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:22:00Z","timestamp":1784305320473,"version":"3.55.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Endocrine and metabolic diseases show increasing incidence and high treatment costs worldwide. Due to the complexity of their etiology and mechanism, therapeutic strategies are still lacking. Osteoprotegerin (OPG), a member of the tumor necrosis factor receptor superfamily, appears to be a potential candidate for the treatment of these diseases. Studies based on clinical analysis and rodent animal models reveal the roles of OPG in various endocrine and metabolic processes or disorders, such as bone remodeling, vascular calcification, and \u03b2-cell proliferation, through the receptor activator of nuclear factor kappa-B ligand (RANKL) and the receptor activator of NF-\u03baB (RANK). Thus, in this review, we mainly focus on relevant diseases, including osteoporosis, cardiovascular disease (CVD), diabetes, and gestational diabetes mellitus (GDM), to summarize the effects of the RANKL\/RANK\/OPG system in endocrine and metabolic tissues and diseases, thereby providing a comprehensive insight into OPG as a potential drug for endocrine and metabolic diseases.<\/jats:p>","DOI":"10.3389\/fcell.2022.1005681","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:57:32Z","timestamp":1667469452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand\/receptor activator of nuclear factor kappa-B signaling"],"prefix":"10.3389","volume":"10","author":[{"given":"Luodan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maozhen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.diabres.2010.09.028","article-title":"Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome","volume":"91","author":"Akinci","year":"2011","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.tig.2015.02.008","article-title":"Epigenetic modifications and long noncoding RNAs influence pancreas development and function","volume":"31","author":"Arnes","year":"2015","journal-title":"Trends Genet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1038\/s41467-019-13139-9","article-title":"A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension","volume":"10","author":"Arnold","year":"2019","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1752854","DOI":"10.1155\/2016\/1752854","article-title":"Roles and clinical applications of OPG and TRAIL as biomarkers in cardiovascular disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.mce.2014.06.004","article-title":"Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes","volume":"394","author":"Bernardi","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1365-2362.2011.02619.x","article-title":"Osteoprotegerin is associated with cardiovascular risk in hypertension and\/or diabetes","volume":"42","author":"Blazquez-Medela","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/s41467-021-22734-8","article-title":"RANKL regulates male reproductive function","volume":"12","author":"Blomberg Jensen","year":"2021","journal-title":"Nat. Commun."},{"key":"B9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1210\/jcem.86.2.7192","article-title":"Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women","volume":"86","author":"Browner","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/ATVBAHA.113.301755","article-title":"Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification","volume":"33","author":"Callegari","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.2337\/dc20-2960","article-title":"Epigenome-wide association study reveals methylation loci associated with offspring gestational diabetes mellitus exposure and maternal methylome","volume":"44","author":"Canouil","year":"2021","journal-title":"Diabetes Care"},{"key":"B12","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1365-2605.2010.01117.x","article-title":"Type 2 diabetes mellitus and testosterone: A meta-analysis study","volume":"34","author":"Corona","year":"2011","journal-title":"Int. J. Androl."},{"key":"B13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrrheum.2012.157","article-title":"The skeleton as an endocrine organ","volume":"8","author":"DiGirolamo","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/10641955.2010.484084","article-title":"The concentrations of markers of bone turnover in normal pregnancy and preeclampsia","volume":"31","author":"Dorota","year":"2012","journal-title":"Hypertens. Pregnancy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/eje.1.02052","article-title":"Osteoprotegerin serum levels in children with type 1 diabetes: A potential modulating role in bone status","volume":"153","author":"Galluzzi","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/cr.2016.79","article-title":"Prevention of breast cancer by RANKL\/RANK blockade","volume":"26","author":"Galluzzi","year":"2016","journal-title":"Cell Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-017-0581-z","article-title":"Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects","volume":"16","author":"Giovannini","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.vph.2016.02.003","article-title":"Vascular calcification in type-2 diabetes and cardiovascular disease: Integrative roles for OPG, RANKL and TRAIL","volume":"82","author":"Harper","year":"2016","journal-title":"Vasc. Pharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"R79","DOI":"10.1530\/JOE-18-0174","article-title":"Chemerin: A multifaceted adipokine involved in metabolic disorders","volume":"238","author":"Helfer","year":"2018","journal-title":"J. Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"563509","DOI":"10.3389\/fcell.2020.563509","article-title":"Placenta-derived osteoprotegerin is required for glucose homeostasis in gestational diabetes mellitus","volume":"8","author":"Huang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13046-018-1001-2","article-title":"RANKL\/RANK\/OPG system beyond bone remodeling: Involvement in breast cancer and clinical perspectives","volume":"38","author":"Infante","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: Recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet. Diabetes Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm.3084","article-title":"Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus","volume":"19","author":"Kiechl","year":"2013","journal-title":"Nat. Med."},{"key":"B26","first-page":"A21","article-title":"Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications","volume":"52","author":"Knudsen","year":"2003","journal-title":"Diabetes"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2015.05.021","article-title":"Osteoprotegerin and denosumab stimulate human beta cell proliferation through inhibition of the receptor activator of NF-kappa B ligand pathway","volume":"22","author":"Kondegowda","year":"2015","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1359\/Jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (Murine\/Human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J. Bone Min. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0146544","DOI":"10.1371\/journal.pone.0146544","article-title":"Osteoprotegerin regulates pancreatic beta-cell homeostasis upon microbial invasion","volume":"11","author":"Kuroda","year":"2016","journal-title":"Plos One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1096\/fasebj.12.10.845","article-title":"TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption","volume":"12","author":"Kwon","year":"1998","journal-title":"FASEB J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fendo.2017.00188","article-title":"Marrow adipose tissue: Skeletal location, sexual dimorphism, and response to sex steroid deficiency","volume":"8","author":"Lecka-Czernik","year":"2017","journal-title":"Front. Endocrinol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/ATVBAHA.118.311874","article-title":"TLR2 promotes vascular smooth muscle cell chondrogenic differentiation and consequent calcification via the concerted actions of osteoprotegerin suppression and IL-6-mediated RANKL induction","volume":"39","author":"Lee","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1038\/s41388-018-0612-6","article-title":"Progesterone receptor integrates the effects of mutated MED12 and altered DNA methylation to stimulate RANKL expression and stem cell proliferation in uterine leiomyoma","volume":"38","author":"Liu","year":"2019","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/jbmr.1606","article-title":"Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX","volume":"27","author":"McCloskey","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.diabet.2016.02.004","article-title":"Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults","volume":"42","author":"Monseu","year":"2016","journal-title":"Diabetes Metab."},{"key":"B36","doi-asserted-by":"publisher","first-page":"E599","DOI":"10.1161\/Cir.0000000000000409","article-title":"Heart disease and stroke statistics-2016 update: A report from the American heart association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1210\/jc.2003-030486","article-title":"Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation","volume":"88","author":"Naylor","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.2337\/db10-1220","article-title":"The RANKL\/RANK\/OPG signaling pathway mediates medial arterial calcification in diabetic charcot neuroarthropathy","volume":"60","author":"Ndip","year":"2011","journal-title":"Diabetes"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41232-019-0111-3","article-title":"RANKL biology: Bone metabolism, the immune system, and beyond","volume":"40","author":"Ono","year":"2020","journal-title":"Inflamm. Regen."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1210\/me.2009-0144","article-title":"The transcriptional response of the islet to pregnancy in mice","volume":"23","author":"Rieck","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"12043","DOI":"10.1021\/acs.jmedchem.0c01316","article-title":"Discovery of small-molecule inhibitors of receptor activator of nuclear factor-\u03bab ligand with a superior therapeutic index","volume":"63","author":"Rinotas","year":"2020","journal-title":"J. Med. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pharmthera.2017.08.015","article-title":"The role of osteoprotegerin in the crosstalk between vessels and bone: Its potential utility as a marker of cardiometabolic diseases","volume":"182","author":"Rochette","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mce.2016.08.047","article-title":"Cellular senescence: Implications for metabolic disease","volume":"455","author":"Schafer","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e44340","DOI":"10.1371\/journal.pone.0044340","article-title":"Expression of osteoprotegerin in placenta and its association with preeclampsia","volume":"7","author":"Shen","year":"2012","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiol.00061.2014","article-title":"Physiological bone remodeling: Systemic regulation and growth factor involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiol. (Bethesda)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","first-page":"5101","DOI":"10.1038\/s41388-018-0324-y","article-title":"RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-\u03baB activation and EGFR signaling","volume":"37","author":"Sirinian","year":"2018","journal-title":"Oncogene"},{"key":"B49","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.clinbiochem.2011.04.016","article-title":"Increased levels of bone remodeling biomarkers (osteoprotegerin and osteopontin) in hypertensive individuals","volume":"44","author":"Stepien","year":"2011","journal-title":"Clin. Biochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5604\/12321966.1152085","article-title":"The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes","volume":"22","author":"Telejko","year":"2015","journal-title":"Ann. Agric. Environ. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.mce.2010.08.019","article-title":"Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets","volume":"331","author":"Toffoli","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1586\/17446651.2015.1058152","article-title":"Searching for additional endocrine functions of the skeleton: Genetic approaches and implications for therapeutics","volume":"10","author":"Wei","year":"2015","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"B53","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1006\/bbrc.2001.5745","article-title":"Immunological study on circulating murine osteoprotegerin\/osteoclastogenesis inhibitory factor (OPG\/OCIF): Possible role of OPG\/OCIF in the prevention of osteoporosis in pregnancy","volume":"288","author":"Yano","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/joim.12348","article-title":"Bone and the regulation of global energy balance","volume":"277","author":"Zhang","year":"2015","journal-title":"J. Intern. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41413-021-00142-4","article-title":"Endocrine role of bone in the regulation of energy metabolism","volume":"9","author":"Zhou","year":"2021","journal-title":"Bone Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.1005681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T09:57:35Z","timestamp":1667469455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2022.1005681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":55,"alternative-id":["10.3389\/fcell.2022.1005681"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2022.1005681","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"article-number":"1005681"}}